Searched for
ZYDUS RESEARCH CENTRE
Regulator, cos discuss price hike for some cancer drugsIndia's drug pricing authority may soon approve a price hike for vital platinum-based cancer medicines. These drugs, including carboplatin ...- From Adani Green to Tata Tech: 50 companies swing back to profit in Q4 despite market turmoilIndian companies show strong recovery. Over 50 firms moved from losses to profits in the March quarter. This turnaround happened despite ma...
- Novo Nordisk’s weight-loss drug patent loss sparks a ‘gold rush’ for generic drugmakersIndia's weight-loss drug market is seeing a major shift. Generic versions of Novo Nordisk's semaglutide are now available at lower prices. ...
- Innovation from India to empower people to lead healthier life: Zydus' Patel on selection for PadmaZydus Lifesciences Chairman Pankaj R Patel has been awarded the prestigious Padma Bhushan for his contributions to the lifesciences industr...
- Zydus gets Mexican regulatory approval to market cancer treatment productThe product is used in the treatment of breast cancer and advanced gastric cancer. Breast cancer has become the most diagnosed cancer in Me...
- Zydus barred from selling cancer biosimilar, for nowThe Delhi High Court has temporarily barred Zydus Lifesciences from selling its breast cancer drug Sigrima, a biosimilar of Roche's Perjeta...
- Centre working on pricing of Zydus Cadila COVID-19 vaccine, launch likely on October 2Its pricing will be decided at a meeting between company representatives and the National Expert Group in Vaccine Administration for Covid ...
- Zydus jab likely to cost more than Covishield, pricing to be out soonZydus Cadila's Covid vaccine, which is likely to be launched next month, may cost more than Covishield but will be comparable with those al...
- Gujarat: PM Modi reviews vaccine development at Zydus Cadila facilityAfter his arrival at Ahmedabad airport from Delhi shortly after 9 am, Modi flew to the Zydus Cadila plant and held discussions with the pro...
- Zydus ties up with US-based research centre NIAD to develop vaccineThe Group employs over 16,500 people worldwide, including over 1,600 scientists in R&D. Cadila Healthcare is part of Zydus Group.
- Zydus Cadila launches biosimilar of AbbVie's Humira in IndiaZydus Cadila today launched biosimilar of Adalimumab, used for treatment of auto immune disorders, at a price much lower than the innovator...
- Zydus to launch first new chemical entity by desi companyCadila Healthcare on Wednesday said that its new chemical entity (NCE), Lipaglyn , has been approved by the Drug Controller General of Indi...
- Symposium on new drug discovery begins at Zydus Research CentreThe symposium is to address various aspects related to new drug discovery with a focus on cancer, inflammation, cardiometabolic diseases an...
- Cadila Healthcare Q3 net dips by 4.4%, sales rise 20%Cadila Healthcare, the flagship company of Zydus group, has suffered a 4.4% drop in its third quarter net profit on account of forex losses.
- Zydus eyes acquisitions to turn consumer arm into Rs 500-cr companyZydus Cadila Group, is looking for an exponential grown of its consumer product subsidiary, Zydus Wellness Ltd (ZWL).
- Zydus files IND application with DCGI for diabetes and obesityHealthcare major, Zydus Cadila has filed IND (Investigational New Drug) application for anti-diabetic and anti-obesity drug with Drugs Cont...
- Zydus eyes $ 300 million revenue generation with Eli LillyZydus Cadila eyes large chunk of revenue generation from its new drug discovery pact with global drug giant Eli Lilly.
- Cadila Healthcare, Karo Bio enter 3 year deal for drug discoveryCadila Healthcare and Karo Bio of Sweden have entered into strategic parternership for three years in the area of drug discovery and develo...
- Cadila files new drug application; share up nearly 1%Cadila Healthcare has filed an investigational new drug application for conducting clinical trials for molecular entity - ZYH7, to treat dy...
- Gujarat next biotech hub, number of cos up 50%Big pharma companies such as Zydus Healthcare plans to focus on biotech in a big way.
Load More
